Our study presents a novel biomarker for chemotherapy-induced protective autophagy and establishes a theoretical and experimental foundation for targeting CLDN6 to enhance chemosensitivity in breast cancer patients. The gene discussed is CLDN6; the disease is breast carcinoma.